MCK
McKESSON CORPORATIONNYSEResearch view
Consumer Defensive · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Large-cap · SEC EDGAR FY 2026-03-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2026-03-31SectorConsumer Defensive
Market Cap$103.4B
Enterprise Value$107.7B
Income$4.8B
Sales$403.4B
Book/sh$-15.24
Cash/sh$34.89
Dividend TTM$3.17
Payout8%
Employees—
IPO—
Quick Ratio0.49
Current Ratio0.85
Debt/Eq-4.66
EPS (ttm)$38.38
EPS this Y49.2%
EPS past 3/5Y15.3%
Sales past 3/5Y13.4%
EPS Y/Y TTM49.2%
Sales Y/Y TTM12.4%
Shs Outstand116.59M
ROA5.8%
ROE-268.0%
ROIC209.2%
Gross Margin3.6%
Oper. Margin1.5%
Profit Margin1.2%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$264.0B
2022
$276.7B
2023
$309.0B
2024
$359.1B
2025
$403.4B
2026
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $264.0B | $276.7B | $309.0B | $359.1B | $403.4B |
| Gross Profit | $13.1B | $12.4B | $12.8B | $13.3B | $14.6B |
| Operating Income | $2.0B | $4.4B | $3.9B | $4.4B | $6.2B |
| Net Income | $1.1B | $3.6B | $3.0B | $3.3B | $4.8B |
| Diluted EPS | $7.23 | $25.03 | $22.39 | $25.72 | $38.38 |
| Operating Cash Flow | $4.4B | $5.2B | $4.3B | $6.1B | $6.2B |
| Free Cash Flow | $4.0B | $4.8B | $3.9B | $5.5B | $5.7B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY26 cash-flow waterfall
Capital-light: capex is $436.0M against $6.2B operating cash
Follow the news. Track the move.
MCK story timeline
Company updates and connected market context, with the dated price move attached.
2
Stories
0
Direct
Sector context/Regulation
Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson
Hackers claim millions of patient records were stolen from McKesson after the healthcare distributor disclosed a cyberattack and warned of intermittent service degradation. The breach puts operational continuity, remediation costs and potential regulatory exposure ahead of the company’s otherwise strong revenue growth.
Price history unavailable
TechCrunch · 17d ago
View both sides →Sector context/Market context
McKesson stock jumps on $2.25B Precision Medicine deal
McKesson shares jumped after the company announced a $2.25B deal for Precision Medicine. The move puts the market’s focus on whether the acquisition can add growth without worsening McKesson’s already-thin profitability.
Price history unavailable
Investing.com · 23d ago
View both sides →COMMUNITY · $MCK0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.